MedTrace Logo

Magnetic Stimulation as a Treatment for Stress Urinary Incontinence

NCT05952258 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2026-04-24

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the efficacy of electromagnetic stimulation treatment of the pelvic floor muscles in adult females with stress urinary incontinence.

Conditions

  • Stress Urinary Incontinence

Interventions

DEVICE

Magnetic stimulation

The magnetic stimulation to the pelvic floor muscle will be provided by the Emsella® chair: which will be activated for 28 minutes at each treatment session. The treatment arm will receive up to 100% intensity at each treatment session.

DEVICE

Sham Magnetic stimulation

The sham arm will receive up to 5% intensity at each treatment session

Sponsors & Collaborators

  • Innovation Fund of the Alternative Funding Plan from the Academic Health Sciences Centres of Ontario

    collaborator UNKNOWN

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • P Lee, MD · Sunnybrook Health Sciences Centre,, University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2027-07-31
Completion
2028-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05952258 on ClinicalTrials.gov